Drugs / iron dextran
iron dextran
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01447628 Comparator | Mar 2011 → Dec 2017 | disorder of iron metabolism and transport, pulmonary arterial hypertension | Imperial College London | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iron dextran | “iron dextran (Cosmofer)” PMID 33735594 ↗ Jun 2021 |
| Known as | Armidexan | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201544 ↗ |
| Known as | CosmoFer | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01447628 ↗ |
| Known as | Ferran 100 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201544 ↗ |
| Known as | Ferrum | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201544 ↗ |
| Known as | Imferon | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201544 ↗ |
| Known as | Nonemic | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201544 ↗ |
| Route | Intravenous | “Intravenous, 1000 mg iron” NCT01447628 ↗ |